Journal article
Donor leukocyte infusions for multiple myeloma
Abstract
Donor leukocyte infusion (dli) has well-documented activity in cml, but the role of dli in other diseases is less well defined. to evaluate the strategy in multiple myeloma (mm) we evaluated 25 mm patients from 15 centers who were treated with dli. patients with persistent or recurrent disease after allogeneic bmt received dli from the original marrow donor (23 matched related, one mismatched family, and one matched unrelated). chemotherapy was …
Authors
Salama M; Nevill T; Marcellus D; Parker P; Johnson M; Kirk A; Porter D; Giralt S; Levine J; Drobyski W
Journal
Bone Marrow Transplantation, Vol. 26, No. 11, pp. 1179–1184
Publisher
Springer Nature
Publication Date
December 1, 2000
DOI
10.1038/sj.bmt.1702685
ISSN
0268-3369